Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis

Zekai Tahir Burak Women's Health Research and Education Hospital80 enrolled

Overview

The aim of this study was to clarify the prognostic value of serum pro-Adrenomedullin level in neonatal sepsis. Eighty term and preterm neonates with sepsis were enrolled in this study. Eighty healthy matched neonates served as a control group.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Sepsis

Eligibility

Sex: ALLMin age: 24 WeeksMax age: 42 WeeksHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical sepsis and/or proven sepsis. Exclusion Criteria: * Acute kidney injury * Intracranial hemorrhage (Grade III and IV)

Locations (1)

Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit

Ankara, Turkey (Türkiye)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.